首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   188篇
  免费   12篇
  国内免费   1篇
耳鼻咽喉   1篇
儿科学   4篇
妇产科学   2篇
基础医学   61篇
口腔科学   2篇
临床医学   9篇
内科学   84篇
皮肤病学   2篇
神经病学   3篇
外科学   5篇
综合类   1篇
预防医学   19篇
药学   5篇
中国医学   2篇
肿瘤学   1篇
  2022年   1篇
  2021年   4篇
  2020年   1篇
  2019年   1篇
  2018年   3篇
  2017年   7篇
  2016年   4篇
  2015年   4篇
  2014年   7篇
  2013年   3篇
  2012年   11篇
  2011年   13篇
  2010年   8篇
  2009年   9篇
  2008年   13篇
  2007年   11篇
  2006年   14篇
  2005年   17篇
  2004年   10篇
  2003年   8篇
  2002年   12篇
  2001年   5篇
  2000年   7篇
  1999年   1篇
  1998年   4篇
  1997年   2篇
  1995年   1篇
  1993年   3篇
  1992年   3篇
  1991年   2篇
  1990年   4篇
  1989年   2篇
  1986年   1篇
  1978年   2篇
  1976年   1篇
  1955年   1篇
  1954年   1篇
排序方式: 共有201条查询结果,搜索用时 31 毫秒
101.
102.
Heterogeneity in malaria exposure is most readily recognized in areas with low-transmission patterns. By comparison, little research has been done on spatial patterns in malaria exposure in high-endemic settings. We determined the spatial clustering of clinical malaria incidence, asymptomatic parasite carriage, and Anopheles density in two villages in Mali exposed to low- and mesoendemic-malaria transmission. In the two study areas that were < 1 km2 in size, we observed evidence for spatial clustering of Anopheles densities or malaria parasite carriage during the dry season. Anopheles density and malaria prevalence appeared associated in some of our detected hotspots. However, many households with high parasite prevalence or high Anopheles densities were located outside the identified hotspots. Our findings indicate that within small villages exposed to low- or mesoendemic-malaria transmission, spatial patterns in mosquito densities and parasite carriage are best detected in the dry season. Considering the high prevalence of parasite carriage outside detected hotspots, the suitability of the area for targeting control efforts to households or areas of more intense malaria transmission may be limited.  相似文献   
103.
Parasite antigen diversity poses an obstacle to developing an effective malaria vaccine. A protein microarray containing Plasmodium falciparum apical membrane antigen 1 (AMA1, n = 57) and merozoite surface protein 1 19-kD (MSP119, n = 10) variants prevalent at a malaria vaccine testing site in Bandiagara, Mali, was used to assess changes in seroreactivity caused by seasonal and lifetime exposure to malaria. Malian adults had significantly higher magnitude and breadth of seroreactivity to variants of both antigens than did Malian children. Seroreactivity increased over the course of the malaria season in children and adults, but the difference was more dramatic in children. These results help to validate diversity-covering protein microarrays as a promising tool for measuring the breadth of antibody responses to highly variant proteins, and demonstrate the potential of this new tool to help guide the development of malaria vaccines with strain-transcending efficacy.Plasmodium falciparum uses antigenic variation to evade host immunity, including vaccine-induced immunity.1,2 The protective immunity against P. falciparum malaria disease that is acquired after years of exposure is believed to reflect, in part, the gradual acquisition of allele-specific immune responses against a repertoire of parasite antigens, and, importantly, against diverse variants of these antigens.3 Apical membrane antigen 1 (AMA1) and merozoite surface protein 1 (MSP1) are immunogenic parasite surface antigens considered vital for erythrocyte attachment and invasion. Antibodies against these proteins are associated with protection against malaria, and several subunit AMA1 and MSP1 vaccines have been developed and tested.1,46 Both AMA1 and MSP119, the C-terminus portion of the MSP1 protein used in subunit vaccines, are highly variable, with sequence diversity encoded by single nucleotide polymorphisms.7,8 The highest prevalence of any one of the 440 AMA1 haplotypes observed from sequencing the ama1 gene among more than 1,400 field infections diagnosed during prospective incidence studies and vaccine trials was less than 4%.1,8,9Although less extreme, MSP119 also has substantial diversity, with 17 haplotypes detected among more than 1,300 infections.7 Because vaccines that include dozens or hundreds of antigen variants are not feasible, malaria vaccine development would be aided by the identification of a manageable number of serodominant, cross-protective haplotypes among AMA1 and MSP119 variants. Developing such strain-transcending vaccines is hindered by the limited availability of diverse parasite antigens and the low throughput of standard assays such as enzyme-linked immunosorbent assay for measuring antibody responses.Protein microarrays offer the possibility of overcoming these obstacles to enable high throughput evaluations of seroreactivity to large numbers of antigen variants. Plasmodium falciparum proteins expressed in a cell-free Escherichia coli translation system and spotted onto microarrays are recognized by serum antibodies of persons exposed to malaria.1012 To date, this platform has been used to measure seroreactivity to large numbers of proteins derived from the genome of the P. falciparum reference strain 3D7.10,1214 To examine antibody responses to diverse variants of highly polymorphic P. falciparum antigens, we amplified, expressed and printed dozens of field-derived variants of AMA1 and MSP119 on a protein microarray.Antigen genes were amplified by polymerase chain reaction from DNA extracted from dried blood spots collected in a cohort study and an AMA1 vaccine trial in Mali, Africa. The resulting amplicons were analyzed by using the BigDye® Terminator v3.1 Cycle Direct Sequencing Kit (Applied Biosciences, Foster City, CA).4,8,15 Sequence contigs were compiled by using Sequencher software (Gene Codes, Ann Arbor, MI).9,16 Sixty of the most prevalent AMA1 ectodomain haplotypes and 10 MSP119 haplotypes were selected for inclusion on the prototype protein microarray. Microarray construction has been described.17Serum samples were obtained from 18 adults 18–55 years of age enrolled in the control arm of a phase 1 trial of an AMA1-based vaccine conducted during 2004–2005 in Bandiagara, Mali.18 Similarly, serum samples were randomly obtained from 24 children 1–6 years of age enrolled in the control arm of a phase 1 trial of an AMA1-based malaria vaccine during 2006–2007 at the same site.6,19 Bandiagara, Mali has high seasonal malaria transmission coinciding with the June–November rainy season, with entomologic inoculation rates of 50–150 infected bites/person/season.8 For each participant, paired serum samples from two time points corresponding to the pre-malaria (May–June) and post-malaria (December–January) seasons were probed in random order to eliminate batch and slide effects.Two microliters of serum from individual participant samples was diluted 1:200 with 10% E. coli lysate in blocking buffer and hybridized onto separate protein arrays overnight. Arrays were stained, washed, and scanned by using a Perkin-Elmer (Waltham, MA) ScanArray Express HT microarray scanner. Probing protocols have been described.10,12,17 Fluorescence was quantified by using the ScanArray Express Suite (Perkin-Elmer). Median fluorescent intensities (MFIs) were calculated by using an adaptive capture feature to account for varying spot size, and the per-spot local background was subtracted.Raw MFIs were asinh-transformed to convert the MFI values to a Gaussian (normal) distribution, and biological variance contributed by seroreactivity to the E. coli components included in the translation protocol was subtracted by taking the average of eight empty vector, translated, negative controls (i.e., the no DNA controls). Residual non-biological variance between slides, batches, and individual arrays was corrected by using robust linear modeling (RLM) with respect to the negative and positive controls.20 Asinh-transformed, RLM-scaled data were reverted to fluorescent intensities by sinh reverse-transformation and plotted on a heat map to show global trends (Figure 1).Open in a separate windowFigure 1.Heat map of seroreactivity to Plasmodium falciparum apical membrane antigen 1 (AMA1) and merozoite surface protein 1–19 (MSP119) variants. Each column represents serum from an individual Malian child or adult, or a malaria-naive North American adult, and each row represents an antigen variant. Gray, black, and red indicate low, moderate and high seroreactivity, respectively, to probed antigens. Four serial dilutions of IgG peptide were printed and probed as positive probing controls and used as a standardization parameter for robust linear model scaling as a measurement of total IgG. MFI = median fluorescent intensity.Parametric statistical hypotheses were tested on asinh-transformed, RLM-scaled data by using BioconductR (http://www.bioconductor.org/index.html, Excel (Microsoft, Redmond, WA), and SAS/STAT software (SAS Institute, Cary, NC). The magnitude of seroreactivity was measured by mean MFI using matched pair Student''s t tests (
AntigenCohortMean MFI (95% CI)Serorecognition (%, 95% CI)
Pre-seasonPost-seasonPre-seasonPost-season
AMA1Children296 (226–365)434 (348–522)13.1 (5.8–20.4)18.6 (11.1– 26.1)
Adults1,506 (1,324–1,687)1,428 (1,271–1,585)49.3 (37.0–61.6)53.2 (42.7–63.7)
Controls8.78 (5.22–12.4)
MSP119Children20.9 (4.40–37.5)191 (110–273)2.5 (–0.9 to 5.9)9.4 (3.5–15.4)
Adults627 (345–909)940 (474–1,406)21.1 (11.4–30.9)18.9 (6.3–31.4)
Controls21.4 (16.8–26.05)
Open in a separate window*Serum samples from Malian children and adult were considered positive for a given antigen variant if the mean MFI was 2 SD above the average of 30 malaria-naive North American controls. Serorecognition is given as the average percentage of AMA1 and MSP119 variants recognized by each cohort at each time point.MFI = median fluorescence intensity; CI = confidence interval; AMA1 = apical membrane antigen 1; MSP119 = merozoite surface protein 1 C-terminal 19 kD.Seroreactivity profiles to AMA1 and MSP119 variants were compared for Malian adults, Malian children, and malaria-naive North American adults. At the beginning of the transmission season, Malian adult serum samples had significantly higher magnitude and breadth of seroreactivity to AMA1 and MSP119 variants than Malian pediatric serum samples and North American malaria-naive control serum samples (P < 0.001, for all comparisons). Post-season serum samples had a higher magnitude and breadth of AMA1 reactivity than pre-season serum samples from Malian children (P < 0.01 for both comparisons). The magnitude and breadth of antibody seroreactivity to MSP119 variants was significantly higher in Malian children at the post-season time point compared with pre-season (P < 0.001). No seasonal difference was observed in seroreactivity to MSP119 variants for adults in magnitude or breadth of antibody response. Assessments of significance were calculated using matched Student''s t test for differences in magnitude data and Poisson regression analysis for the comparison of antibody breadth.Multiplicity of infection is a concern when working with field samples from an area where 64–87% of malaria infections in adults are multiple clone infections with respect to the ama1 haplotype.21 Among 600 malaria infections, 21% were polyclonal with respect to ama1, making haplotype determination impossible.15 We used single-colony isolation to sequence clonal AMA1 and MSP119 plasmid-containing E. coli and evaluated a kit to translate proteins with disulfide bonds (RTSS) (5 Prime, Hilden, Germany). Single-colony-extracted proteins with disulfide bonds had significantly higher signal-to-noise ratios than any other preparation protocol, despite the increased background seroreactivity of negative controls.Despite using antigen variants and serum samples from the same site, six variants on the array were unrecognized above background at any time point. This lack of seroreactivity could represent allele specificity, or alternatively incorrect folding of reactive epitopes in these particular variants during translation. We also detected eight AMA1 variants that were recognized by most serum samples from adults.A previous study in southern Mali found no differences in seroreactivity to AMA1 and MSP1 in children who had none versus one or more clinical malaria episodes, but this analysis used a protein microarray with the P. falciparum reference proteome 3D7.12 The lack of association could be because the parasites causing illness had AMA1 and MSP1 variants distinct from those in the reference genome. In contrast, our diversity-covering protein array makes it possible for the first time to study the strain-specificity of antibody responses in a high throughput fashion.In the 3D7 protein microarray study, serum from persons exposed to malaria had higher reactivity against a full-length MSP1 protein than against AMA1, whereas the seroreactivity to MSP119 in this study was significantly less than to AMA1.12 This finding may be explained by the relative sizes of the protein fragments. In this study, we translated the entire AMA1 ectodomain, but used only the 19-kD post-cleavage fragment of MSP1 that serves as a vaccine antigen. We will compare seroreactivity to different-sized fragments of MSP1 and AMA1 in subsequent studies.Protein microarrays have limitations. They cannot measure antibody function, and seroreactivity to any one of the large number of antigenic variants on an array does not provide the level of confidence obtained from results of an enzyme-linked immunosorbent assay that measures antibody responses to a protein that has been shown to be correctly folded. Nevertheless, this prototype array represents an enabling technology that will make it possible to evaluate antibody responses to large numbers of antigenic variants among large numbers of individual serum samples to assess immunologic responses in relation to important phenotypes, such as clinical immunity or vaccine-induced protection at a population level. This study was not powered to correlate antibody reactivity to clinical outcomes. The next iteration of the array will include many more variants of AMA1 and other antigens, and will be used to explore the role of allele-specific antibody responses in naturally acquired and vaccine-induced immune protection. Next-generation P. falciparum protein arrays will be used to study allele-specific naturally acquired and vaccine-induced immunity and to inform the design of broadly efficacious strain-transcending malaria vaccines.  相似文献   
104.
P. falciparum malaria prevalence among blood donors in Bamako,Mali     
B. Kouriba  A.B. Diarra  I. Douyon  D.T. Diabaté  F. Kamissoko  H. Guitteye  M. Baby  M.A. Guindo  O.K. Doumbo 《Transfusion Clinique et Biologique》2017,24(2):62-67

Aim

Malaria parasite is usually transmitted to humans by Anopheles mosquitoes but it can also be transmitted through blood transfusion. Usually malaria transmission is low in African urban settings. In West Africa where the P. falciparum is the most predominant malaria species, there are limited measures to reduce the risk of blood transfusion malaria. The aim of this study was to evaluate the prevalence of P. falciparum malaria carriage among blood donors in the National Blood Center of Bamako, capital city of Mali.

Methods

The study was conducted using a random sample of 946 blood donors in Bamako, Mali, from January to December 2011. Screening for malaria was performed by thick smear and rapid diagnostic test (RDT). Blood group was typed by Beth-Vincent and Simonin techniques.

Results

The frequency of malaria infection was 1.4% by thick smear and 0.8% by the RDT. The pick prevalence of P. falciparum malaria was in rainy season, indicating a probable high seasonal risk of malaria by blood transfusion, in Mali. The prevalence of P. falciparum infection was 2% among donors of group O the majority being in this group.

Conclusion

There is a seasonal prevalence of malaria among blood donors in Bamako. A prevention strategy of transfusion malaria based on the combination of selection of blood donors through the medical interview, promoting a voluntary low-risk blood donation and screening all blood bags intended to be transfused to children under 5, pregnant women and immune-compromised patients during transmission season using thick smear will reduce the risk of transfusion malaria in Mali.  相似文献   
105.
The etiology of severe anemia in a village and a periurban area in Mali          下载免费PDF全文
Dicko A  Klion AD  Théra MA  Sagara I  Yalcouyé D  Niambele MB  Sogoba M  Dolo G  Dao A  Diallo DA  Doumbo OK  Miller LH 《Blood》2004,104(4):1198-1200
Severe anemia is one of the major complications of malaria in Africa. We studied 2 populations, one in a village and the second in a periurban area in Mali, to understand the preventable factors in the disease. The 2 correlates of disease were parasitemia above 100 000 parasitized red blood cells per microliter (0.1 x 10(12)/L) and a low baseline hemoglobin level. All cases of moderate to severe anemia occurred in children under 3.2 years of age. Raising the baseline hemoglobin level and lowering peak parasitemia in infants and young children may reduce the incidence of severe anemia resulting from malarial infection.  相似文献   
106.
Malaria incidence in relation to rice cultivation in the irrigated Sahel of Mali     
Sissoko MS  Dicko A  Briët OJ  Sissoko M  Sagara I  Keita HD  Sogoba M  Rogier C  Touré YT  Doumbo OK 《Acta tropica》2004,89(2):161-170
Seven repeated cross-sectional parasitological surveys, collecting a total of 13,912 blood samples, were carried out from September 1995 to February 1998 in three irrigated rice growing villages and three villages without irrigated agriculture in the area surrounding Niono, Mali. Parasite prevalence varied according to season and agricultural zone, but showed similar patterns for villages within the same zone. Overall, malaria prevalence was 47% in the villages without irrigated agriculture and 34% in the irrigated rice growing villages. In a village in the irrigated zone, and a village in the non-irrigated zone, 1067 and 608 children up to the age of 14 years, respectively, were followed in a passive malariological study for the period of 13 months. Fevers were attributed to malaria using a statistical method, taking into account the parasitaemia in afebrile controls from the cross-sectional surveys. The incidence of malaria fevers differed markedly between the two zones and over time. In the village in the irrigated zone, the incidence of malaria fevers was fairly constant over the year at 0.7 per 1000 children per day. In the village without irrigated agriculture, incidence was low during the dry season (at 0.6 per 1000 children per day), whereas it was high during the rainy season (at 3.2 per 1000 children per day). These results correspond well to the malaria transmission observed in a concurrent entomological survey. Rice cultivation in the semi-arid sub-Saharan environment altered the transmission pattern from seasonal to perennial, but reduced annual incidence more than two-fold.  相似文献   
107.
Clinical study using novel endoscopic system for measuring size of gastrointestinal lesion     
Kiyoshi Oka  Takeshi Seki  Tomohiro Akatsu  Takao Wakabayashi  Kazuo Inui  Junji Yoshino 《World journal of gastroenterology : WJG》2014,20(14):4050-4058
AIM:To verify the performance of a lesion size measurement system through a clinical study.METHODS:Our proposed system,which consists of a conventional endoscope,an optical device,an optical probe,and a personal computer,generates a grid scale to measure the lesion size from an endoscopic image.The width of the grid scale is constantly adjusted according to the distance between the tip of the endoscope and lesion because the lesion size on an endoscopic image changes according to the distance.The shape of the grid scale was corrected to match the distortion of the endoscopic image.The distance was calculated using the amount of laser light reflected from the lesion through an optical probe inserted into the instrument channel of the endoscope.The endoscopist can thus measure the lesion size without contact by comparing the lesion with the size of the grid scale on the endoscopic image.(1)A basic test was performed to verify the relationship between the measurement error eM and the tilt angle of the endoscope;and(2)The sizes of three colon polyps were measured using our system during endoscopy.These sizes were immediately measured by scale after their removal.RESULTS:There was no error atα=0°.In addition,the values of eM(mean±SD)were 0.24±0.11 mm(α=10°),0.90±0.58 mm(α=20°)and 2.31±1.41mm(α=30°).According to these results,our system has been confirmed to measure accurately when the tilt angle is less than 20°.The measurement error was approximately 1 mm in the clinical study.Therefore,it was concluded that our proposed measurement system was also effective in clinical examinations.CONCLUSION:By combining simple optical equipment with a conventional endoscope,a quick and accurate system for measuring lesion size was established.  相似文献   
108.
Fc gamma Receptor IIa‐H131R Polymorphism and Malaria Susceptibility in Sympatric Ethnic Groups,Fulani and Dogon of Mali     
B. Maiga  O. Touré  V. Dara  A. Tapily  S. Campino  N. Sepulveda  P. Corran  K. Rockett  O. K. Doumbo 《Scandinavian journal of immunology》2014,79(1):43-50
It has been previously shown that there are some interethnic differences in susceptibility to malaria between two sympatric ethnic groups of Mali, the Fulani and the Dogon. The lower susceptibility to Plasmodium falciparum malaria seen in the Fulani has not been fully explained by genetic polymorphisms previously known to be associated with malaria resistance, including haemoglobin S (HbS), haemoglobin C (HbC), alpha‐thalassaemia and glucose‐6‐phosphate dehydrogenase (G6PD) deficiency. Given the observed differences in the distribution of FcγRIIa allotypes among different ethnic groups and with malaria susceptibility that have been reported, we analysed the rs1801274‐R131H polymorphism in the FcγRIIa gene in a study of Dogon and Fulani in Mali (n = 939). We confirm that the Fulani have less parasite densities, less parasite prevalence, more spleen enlargement and higher levels of total IgG antibodies (anti‐CSP, anti‐AMA1, anti‐MSP1 and anti‐MSP2) and more total IgE (P < 0.05) compared with the Dogon ethnic group. Furthermore, the Fulani exhibit higher frequencies of the blood group O (56.5%) compared with the Dogon (43.5%) (P < 0.001). With regard to the FcγRIIa polymorphism and allele frequency, the Fulani group have a higher frequency of the H allele (Fulani 0.474, Dogon 0.341, P < 0.0001), which was associated with greater total IgE production (P = 0.004). Our findings show that the FcγRIIa polymorphism might have an implication in the relative protection seen in the Fulani tribe, with confirmatory studies required in other malaria endemic settings.  相似文献   
109.
Plasmodium falciparum–specific IgM B cells dominate in children,expand with malaria,and produce functional IgM     
Christine S. Hopp  Padmapriya Sekar  Ababacar Diouf  Kazutoyo Miura  Kristin Boswell  Jeff Skinner  Christopher M. Tipton  Mary E. Peterson  Michael J. Chambers  Sarah Andrews  Jinghua Lu  Joshua Tan  Shanping Li  Safiatou Doumbo  Kassoum Kayentao  Aissata Ongoiba  Boubacar Traore  Silvia Portugal  Peter D. Sun  Carole Long  Richard A. Koup  Eric O. Long  Adrian B. McDermott  Peter D. Crompton 《The Journal of experimental medicine》2021,218(4)
IgG antibodies play a role in malaria immunity, but whether and how IgM protects from malaria and the biology of Plasmodium falciparum (Pf)–specific IgM B cells is unclear. In a Mali cohort spanning infants to adults, we conducted longitudinal analyses of Pf- and influenza-specific B cells. We found that Pf-specific memory B cells (MBCs) are disproportionally IgM+ and only gradually shift to IgG+ with age, in contrast to influenza-specific MBCs that are predominantly IgG+ from infancy to adulthood. B cell receptor analysis showed Pf-specific IgM MBCs are somatically hypermutated at levels comparable to influenza-specific IgG B cells. During acute malaria, Pf-specific IgM B cells expand and upregulate activation/costimulatory markers. Finally, plasma IgM was comparable to IgG in inhibiting Pf growth and enhancing phagocytosis of Pf by monocytes in vitro. Thus, somatically hypermutated Pf-specific IgM MBCs dominate in children, expand and activate during malaria, and produce IgM that inhibits Pf through neutralization and opsonic phagocytosis.  相似文献   
110.
Prévalence de Plasmodium falciparum, de l’anémie et des marqueurs moléculaires de la résistance à la chloroquine et à la sulfadoxine-pyrim éthamine chez les femmes accouchées à Fana, Mali     
S. Doumbo  O. A. Ongoiba  D. Doumtabé  A. Dara  T. D. Ouologuem  K. Kayentao  A. Djimdé  B. Traoré  O. K. Doumbo 《Bulletin de la Societe de pathologie exotique (1990)》2013,106(3):188-192
The aim of this study was to describe the malaria morbidity and the frequencies of molecular markers of resistance to chloroquine and sulfadoxine-pyrimethamine in pregnant women at delivery in Mali. Two hundred pregnant women have been included at the delivery clinic in Fana. The age group of 14–19 years was predominant. Fifty two per cent (52.3%: 104/200) were malaria slides positive in their peripheral blood and 15% (30/200) of the women carried parasite in their placenta. The prevalence rate of anemia was 44.5% (89/200). PCR technique was successfully performed on 16 paired samples. The frequency of the Pfcrt K76T mutants in Plasmodium falciparum infections in peripheral blood was 68.8% (11/16) and 100 % (16/16) in the placenta (p = 0.004). The frequency in peripheral blood of the DHFR N51I mutation was 12.5% (2/16) and 18.8% (3/16) in the placenta (p=0.12). The frequencies of the DHPS A437G mutants were similar in both sites 25% (4/16). No DHPS K540E and DHFR 164L mutations were found in the Fana pregnancy women samples.  相似文献   
[首页] « 上一页 [6] [7] [8] [9] [10] 11 [12] [13] [14] [15] [16] 下一页 » 末  页»
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号